News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
151 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17848)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates
The Company also provided several corporate updates.
January 9, 2018
·
8 min read
Business
I-MED Pharma: I-PEN, I-DROP and I-PLUG Now Available in Spain and Portugal Through Partnership With IMEX
The deal also includes other dry eye products for Spain and Portugal.
January 9, 2018
·
2 min read
Policy
ZOLL First Company to Receive Premarket Approval from the FDA on Its Full Portfolio of Defibrillators
ZOLL announced that it is the first company to achieve premarket approval (PMA) by the FDA to continue to market and distribute its full line of defibrillators in the U.S.
January 9, 2018
·
2 min read
Business
World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board
The newly formed Board of Advisors will provide deep scientific and clinical expertise to the company as it discovers and advances new treatments for IPF based on NuMedii’s AIDD technology.
January 9, 2018
·
3 min read
Business
BioSyent Announces Changes to Its Board of Directors
BioSyent also announced the appointment of Mr. Larry Andrews and Ms. Sara Elford to its Board of Directors.
January 9, 2018
·
4 min read
Business
Vaccinex Announces Research Collaboration Employing ActivMAb Platform Technology and Antibody License Option Agreement With Surface Oncology
Surface Oncology will have the option to obtain exclusive worldwide rights to antibodies discovered during the research program.
January 9, 2018
·
4 min read
Business
Simulations Plus Reports First Quarter FY2018 Financial Results
Simulations Plus today reported financial results for its first quarter of fiscal year 2018, the period ended November 30, 2017 (1QFY18).
January 9, 2018
·
6 min read
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Clopidogrel Tablets USP, 75 Mg Packaged in Bottles of 30 Tablets Due to Mislabeling
International Laboratories is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling.
January 9, 2018
·
2 min read
Viemed Announces Further Details of Plan of Arrangement and Engagement of IR Firm
As a result of the foregoing adjustments, Viemed has 878,298 Viemed Options outstanding, with exercise prices ranging from $1.44 to $8.44 and expiry dates ranging from February 9, 2018 to July 28, 2025.
January 9, 2018
·
9 min read
Genetown
Broad Institute Releases Open-Source GATK4 Software for Genome Analysis, Optimized for Speed and Scalability
Today the Broad Institute of MIT and Harvard is releasing version 4.0 of the Genome Analysis Toolkit, the institute’s flagship genome variant discovery package for analysis of high-throughput sequencing data.
January 9, 2018
·
7 min read
Previous
12 of 16
Next